Apply flexible band to that......remember it was September...then November, now your touting December? Timelines slip and slip, surely priority to regain face and investor confidence first and foremost is get the Type A inked in.....mid November.
Steps after that can take there own course, shorts may have a different view but I think they might be betting on a rejection for the meeting...gutsy but not without some merit given the surprise "news" of late both pre-ODAC and post FDA.....quite a firewalk so far.
Market completely non plussed by ARDS P3 trial update, even with the Covid factor the company cannot sway the market makers.
GLTAH I for 1 cannot compare it to any Stockmarket experience so far...yet I remain very interested.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-322
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |